Okoliegbe, I.N.; Hijazi, K.; Cooper, K.; Ironside, C.; Gould, I.M.
Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics 2021, 10, 967.
https://doi.org/10.3390/antibiotics10080967
AMA Style
Okoliegbe IN, Hijazi K, Cooper K, Ironside C, Gould IM.
Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics. 2021; 10(8):967.
https://doi.org/10.3390/antibiotics10080967
Chicago/Turabian Style
Okoliegbe, Ijeoma N., Karolin Hijazi, Kim Cooper, Corinne Ironside, and Ian M. Gould.
2021. "Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosa" Antibiotics 10, no. 8: 967.
https://doi.org/10.3390/antibiotics10080967
APA Style
Okoliegbe, I. N., Hijazi, K., Cooper, K., Ironside, C., & Gould, I. M.
(2021). Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics, 10(8), 967.
https://doi.org/10.3390/antibiotics10080967
